Portal de Periódicos da CAPES

A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICC

2009; Wiley; Volume: 99; Issue: 5 Linguagem: Inglês

10.1002/jso.21237

1096-9098

Frederick L. Greene, Leslie H. Sobin,

Colorectal Cancer Treatments and Studies

Journal of Surgical OncologyVolume 99, Issue 5 p. 269-272 Guest EditorialFree Access A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICC†‡ Frederick L. Greene MD, Corresponding Author Frederick L. Greene MD [email protected] Department of Surgery, Carolinas Medical Center, Charlotte, North Carolina and Past Chair, American Joint Committee on Cancer, Chicago, IllinoisDepartment of Surgery, Carolinas Medical Center, 1000 Blythe Boulevard, MEB 601, Charlotte, NC 28203, Fax: 704-355-5619.Search for more papers by this authorLeslie H. Sobin MD, Leslie H. Sobin MD Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, District of Columbia TNM-Prognostic Factors Project, International Union Against Cancer, Geneva, Switzerland Chief (Gastrointestinal Pathology, Armed Forces Insitute of Pathology); Chairman (TNM-Prognostic Factors Project, International Union Against Cancer).Search for more papers by this author Frederick L. Greene MD, Corresponding Author Frederick L. Greene MD [email protected] Department of Surgery, Carolinas Medical Center, Charlotte, North Carolina and Past Chair, American Joint Committee on Cancer, Chicago, IllinoisDepartment of Surgery, Carolinas Medical Center, 1000 Blythe Boulevard, MEB 601, Charlotte, NC 28203, Fax: 704-355-5619.Search for more papers by this authorLeslie H. Sobin MD, Leslie H. Sobin MD Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, District of Columbia TNM-Prognostic Factors Project, International Union Against Cancer, Geneva, Switzerland Chief (Gastrointestinal Pathology, Armed Forces Insitute of Pathology); Chairman (TNM-Prognostic Factors Project, International Union Against Cancer).Search for more papers by this author First published: 17 March 2009 https://doi.org/10.1002/jso.21237Citations: 125 † This article is a US Government work and, as such, is in the public domain in the United States of America. ‡ The opinions and assertions contained herein are the expressed views of the author (L.H.S.) and are not to be construed as official or reflecting the views of the Departments of the Army or Defense, The authors have no financial relationship with any products or publications discussed in this article. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Denoix PF: Cancer Staging using anatomical markers. Bull Inst Nat Hyg (Paris) 1950; 5: 81– 86. 2 IF Tannock, RP Hill: editors. The basic science of oncology, 3rd edition. New York: McGraw-Hill; 1998. 3 MK Gospodarowicz, DE Henson, RVP Hutter, et al.: editors. Prognostic factors in cancer, 2nd edition. New York: John Wiley and Sons; 2001. 4 FL Greene, DL Page, ID Fleming, et al.: editors. AJCC cancer staging manual, 6th edition. New York: Springer; 2002. 5 LH Sobin, C Wittekind: editors. TNM classification of malignant tumours, 6th edition. New York: Wiley-Liss; 2002. 6 ID Fleming, JS Cooper, DE Henson, et al.: editors. AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven; 1997. 7 LH Sobin, C Wittekind: editors. TNM classification of malignant tumours, 5th edition. New York: Wiley-Liss; 1997. 8 Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622– 3634. 9 Piccirillo JF, Feinstein AR: Clinical symptoms and comorbidity: Significance for the prognostic classification of cancer. Cancer 1996; 77: 834– 842. 10 Begg CB, Cramer LD, Hoskins WJ, et al.: Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747– 1751. 11 Hillner BE, Smith TJ, Desch CE, et al.: physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 2000; 18: 2327– 2340. 12 Freeman HP: Poverty, culture and social injustice: Determinants of cancer disparities. CA Cancer J Clin 2004; 54: 72– 77. 13 Wittekind C, Compton CC, Greene FL, et al.: TNM residual tumor classification revisited. Cancer 2002; 94: 2511– 2516. 14 Singletary SE, Greene FL, Sobin LH: Classification of isolated tumor cells: Clarification of the 6th edition of the AJCC Cancer Staging Manual. Cancer 2003; 98: 2740– 2741. 15 Winchester DP, Stewart AK, Bura C, et al.: The National Cancer Data Base: A clinical surveillance and quality improvement tool. J Surg Oncol 2004; 85: 1– 3. 16 Greene FL, Stewart AK, Norton HJ: A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients. Ann Surg 2002; 236: 416– 421. 17 Greene FL, Stewart AK, Norton HJ: New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: An analysis. J Clin Oncol 2004; 22: 1778– 1784. 18 Gospodarowicz MK, Miller D, Groome PA et al.: The process for continuous improvement of the TNM classification. Cancer 2004; 100: 1– 5. 19 Greene FL, Sobin LH: The TNM system: Our language for cancer care. J Surg Oncol 2002; 80: 119– 120. Citing Literature Volume99, Issue51 April 2009Pages 269-272 ReferencesRelatedInformation